January 12, 2015 / 7:11 AM / 4 years ago

AC Immune strikes up to $509 mln Alzheimer's deal with J&J

Jan 12 (Reuters) - Swiss biotech firm AC Immune said on Monday it had struck an exclusive worldwide license agreement potentially worth up to $509 million with Johnson & Johnson to develop so-called anti-Tau vaccines for Alzheimer’s disease.

Reporting by Ben Hirschler

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below